Bayer AG (BAYRY)
7.27
+0.01
(+0.14%)
USD |
OTCM |
Apr 25, 16:04
Bayer Revenue (TTM): 51.53B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 51.53B |
September 30, 2023 | 51.03B |
June 30, 2023 | 51.13B |
March 31, 2023 | 52.74B |
December 31, 2022 | 53.72B |
September 30, 2022 | 54.16B |
June 30, 2022 | 54.33B |
March 31, 2022 | 53.76B |
December 31, 2021 | 52.18B |
September 30, 2021 | 51.39B |
June 30, 2021 | 49.80B |
March 31, 2021 | 47.79B |
December 31, 2020 | 47.11B |
September 30, 2020 | 47.10B |
June 30, 2020 | 48.08B |
March 31, 2020 | 49.04B |
December 31, 2019 | 48.79B |
September 30, 2019 | 48.70B |
June 30, 2019 | 48.54B |
March 31, 2019 | 47.82B |
December 31, 2018 | 45.13B |
September 30, 2018 | 43.44B |
June 30, 2018 | 42.10B |
March 31, 2018 | 40.37B |
December 31, 2017 | 39.46B |
Date | Value |
---|---|
September 30, 2017 | 38.85B |
June 30, 2017 | 38.63B |
March 31, 2017 | 42.42B |
December 31, 2016 | 45.18B |
September 30, 2016 | 48.01B |
June 30, 2016 | 51.02B |
March 31, 2016 | 50.92B |
December 31, 2015 | 51.24B |
September 30, 2015 | 52.37B |
June 30, 2015 | 53.35B |
March 31, 2015 | 54.12B |
December 31, 2014 | 55.18B |
September 30, 2014 | 55.16B |
June 30, 2014 | 54.73B |
March 31, 2014 | 54.23B |
December 31, 2013 | 53.33B |
September 30, 2013 | 52.66B |
June 30, 2013 | 51.95B |
March 31, 2013 | 51.47B |
December 31, 2012 | 51.10B |
September 30, 2012 | 50.70B |
June 30, 2012 | 50.87B |
March 31, 2012 | 51.15B |
December 31, 2011 | 50.85B |
September 30, 2011 | 50.70B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
47.10B
Minimum
Sep 2020
54.33B
Maximum
Jun 2022
50.57B
Average
51.03B
Median
Sep 2023
Revenue (TTM) Benchmarks
Affimed NV | 8.941M |
InflaRx NV | -- |
MorphoSys AG | 257.99M |
BioNTech SE | 4.122B |
Immatics NV | 58.49M |